Suppr超能文献

养老院患者的药物使用频度、变异性及其相关因素。

Rates, variability, and associated factors of polypharmacy in nursing home patients.

机构信息

Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel ; Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel.

Department of Geriatric Rehabilitation, Sheba Medical Center, Tel Hashomer, Israel.

出版信息

Clin Interv Aging. 2013;8:1585-90. doi: 10.2147/CIA.S52698. Epub 2013 Nov 28.

Abstract

OBJECTIVES

To determine the rate and variability of polypharmacy in nursing home (NH) residents and investigate its relationship to age, sex, functional status, length of stay, and comorbidities.

METHODS

We conducted a cross sectional, multicenter study that included six nursing homes. Demographic, clinical characteristics, Charlson comorbidity index (CCI), the number and classes of chronic medications, rate of polypharmacy >5 drugs (per day) and polypharmacy >7 drugs (per day) were recorded.

RESULTS

Nine hundred and ninety-three residents were included; 750 (75.5%) fully dependent residents and 243 (24.5%) mobile demented residents requiring institutional care. The mean age was 85.04±7.55 (65-108) years. The mean rates of polypharmacy >5 drugs and polypharmacy >7 drugs were 42.6% and 18.6%, respectively. Differences in polypharmacy >5 drugs and polypharmacy >7 drugs were observed in NHs 24.7%-56% and 4.9%-30.4%, respectively (P<0.001). Mean number of chronic drugs per resident was 5.14±2.60 from 3.81±2.24 to 5.95±2.73 (P<0.001). No differences in polypharmacy were found between sex and fully dependent versus mobile demented residents. The most common medications taken were for gastrointestinal, neurological, and cardiovascular disorders. Regression analysis revealed four independent variables for polypharmacy >5 drugs: groups aged 75-84 and >85 relative to 65-74, odds ratio (OR) 0.46 (95% confidence interval [CI] 0.27-0.78) P=0.004, OR 0.35 (95% confidence interval 0.19-0.53), respectively, P<0.001; length of stay >2 years, OR 0.51 (95% CI 0.36-0.73) P<0.001; CCI, OR 1.58 (95% CI 1.42-1.75) P<0.001; and feeding tube versus normal feeding, OR 0.27 (95% CI 0.12-0.60) P=0.001.

CONCLUSION

Rates of polypharmacy in NHs are high with significant variability. Variability rates of polypharmacy, distinct residents' characteristics, and excessive use of certain drug groups may indicate that a decrease in medication is potentially feasible.

摘要

目的

确定养老院(NH)居民的多种药物使用的发生率和变异性,并调查其与年龄、性别、功能状态、入住时间和合并症的关系。

方法

我们进行了一项横断面、多中心研究,包括六家养老院。记录了人口统计学、临床特征、Charlson 合并症指数(CCI)、慢性药物的数量和种类、每天使用>5 种药物(每剂)和每天使用>7 种药物(每剂)的发生率。

结果

共纳入 993 名居民;750 名(75.5%)完全依赖的居民和 243 名(24.5%)需要机构护理的移动痴呆居民。平均年龄为 85.04±7.55 岁(65-108)。每天使用>5 种药物和每天使用>7 种药物的平均发生率分别为 42.6%和 18.6%。NH24.7%-56%和 4.9%-30.4%之间观察到每天使用>5 种药物和每天使用>7 种药物的差异(P<0.001)。每位居民慢性药物的平均数量从 3.81±2.24 增加到 5.95±2.73(P<0.001)。性别、完全依赖与移动痴呆居民之间的药物使用无差异。最常见的药物用于胃肠道、神经和心血管疾病。回归分析显示,每天使用>5 种药物的四个独立变量为:年龄组 75-84 岁和>85 岁相对于 65-74 岁,比值比(OR)0.46(95%置信区间 [CI] 0.27-0.78)P=0.004,OR 0.35(95%置信区间 0.19-0.53),分别,P<0.001;入住时间>2 年,OR 0.51(95% CI 0.36-0.73)P<0.001;CCI,OR 1.58(95% CI 1.42-1.75)P<0.001;和喂养管与正常喂养,OR 0.27(95% CI 0.12-0.60)P=0.001。

结论

NH 中多种药物使用的发生率很高,且存在显著差异。多种药物使用的变异性、不同居民的特征和某些药物组的过度使用可能表明潜在地减少药物治疗是可行的。

相似文献

1
Rates, variability, and associated factors of polypharmacy in nursing home patients.
Clin Interv Aging. 2013;8:1585-90. doi: 10.2147/CIA.S52698. Epub 2013 Nov 28.
2
Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
Am J Geriatr Pharmacother. 2010 Feb;8(1):63-72. doi: 10.1016/j.amjopharm.2010.01.001.
3
Does Polypharmacy in Nursing Homes Affect Long-Term Mortality?
J Am Geriatr Soc. 2016 Jul;64(7):1432-8. doi: 10.1111/jgs.14213. Epub 2016 Jun 15.
4
Polypharmacy in nursing home in Europe: results from the SHELTER study.
J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):698-704. doi: 10.1093/gerona/glr233. Epub 2012 Jan 4.
5
Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.
Alzheimers Dement. 2013 Sep;9(5):587-93. doi: 10.1016/j.jalz.2012.09.009. Epub 2012 Dec 8.
6
The impact of polypharmacy on 30-day COVID-related mortality in nursing home residents: a multicenter retrospective cohort study.
Eur Geriatr Med. 2023 Feb;14(1):51-57. doi: 10.1007/s41999-022-00723-4. Epub 2022 Dec 9.
7
Potentially inappropriate drug prescribing and associated factors in nursing homes.
J Am Med Dir Assoc. 2014;15(11):850.e1-9. doi: 10.1016/j.jamda.2014.08.003. Epub 2014 Oct 3.
9
Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors.
J Am Med Dir Assoc. 2019 Sep;20(9):1116-1120. doi: 10.1016/j.jamda.2019.01.130. Epub 2019 Mar 8.
10
Characteristics of Long-Term Care Residents That Predict Adverse Events after Hospitalization.
J Am Geriatr Soc. 2020 Nov;68(11):2551-2557. doi: 10.1111/jgs.16770. Epub 2020 Aug 20.

引用本文的文献

1
A Review of Risk Factors for Polypharmacy: Age, Level of Education, and Physician's Attitude.
Cureus. 2024 Oct 19;16(10):e71868. doi: 10.7759/cureus.71868. eCollection 2024 Oct.
3
Assisted living or nursing home: Who is moving in?
J Am Geriatr Soc. 2023 Nov;71(11):3480-3488. doi: 10.1111/jgs.18503. Epub 2023 Jul 14.
4
Polypharmacy and potential drug-drug interactions among Greenland's care home residents.
Ther Adv Drug Saf. 2022 Jun 26;13:20420986221103918. doi: 10.1177/20420986221103918. eCollection 2022.
6
Prevalence and Associated Factors of Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.
Int J Environ Res Public Health. 2021 Feb 19;18(4):2037. doi: 10.3390/ijerph18042037.
7
Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.
Gastroenterology. 2021 Jan;160(2):507-523. doi: 10.1053/j.gastro.2020.09.060. Epub 2020 Dec 8.
8
An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study.
Front Pharmacol. 2020 Mar 18;11:326. doi: 10.3389/fphar.2020.00326. eCollection 2020.
9
Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.
Drugs Aging. 2019 Aug;36(8):733-745. doi: 10.1007/s40266-019-00680-x.
10
Polypharmacy in patients with multiple sclerosis: a gender-specific analysis.
Biol Sex Differ. 2019 May 27;10(1):27. doi: 10.1186/s13293-019-0243-9.

本文引用的文献

2
Outcomes of polypharmacy in nursing home residents.
Clin Geriatr Med. 2012 May;28(2):217-36. doi: 10.1016/j.cger.2012.01.005. Epub 2012 Feb 23.
3
Factors associated with polypharmacy in nursing home residents.
Clin Geriatr Med. 2012 May;28(2):199-216. doi: 10.1016/j.cger.2012.01.004. Epub 2012 Feb 23.
4
Polypharmacy, adverse drug reactions, and geriatric syndromes.
Clin Geriatr Med. 2012 May;28(2):173-86. doi: 10.1016/j.cger.2012.01.002.
5
Factors leading to excessive polypharmacy.
Clin Geriatr Med. 2012 May;28(2):159-72. doi: 10.1016/j.cger.2012.01.001. Epub 2012 Feb 15.
6
Frailty in the older surgical patient: a review.
Age Ageing. 2012 Mar;41(2):142-7. doi: 10.1093/ageing/afr182.
7
High-risk prescribing and incidence of frailty among older community-dwelling men.
Clin Pharmacol Ther. 2012 Mar;91(3):521-8. doi: 10.1038/clpt.2011.258. Epub 2012 Feb 1.
8
Polypharmacy in nursing home in Europe: results from the SHELTER study.
J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):698-704. doi: 10.1093/gerona/glr233. Epub 2012 Jan 4.
9
Exploring variation in rates of polypharmacy across long term care homes.
J Am Med Dir Assoc. 2012 Mar;13(3):309.e15-21. doi: 10.1016/j.jamda.2011.07.001. Epub 2011 Aug 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验